Finance & valuation

Latest content

How the IVSC is preparing to accelerate intangible assets valuation in Asia

After establishing an office in Asia, the CEO of the International Valuation Standards Council expands on plans to escalate intangible assets valuation in the region

26 July 2022

Lessons from China's $46 billion IP financing market

After over a decade and the involvement of various stakeholders, China achieved $46 billion in IP financing in 2021

08 July 2022

Pfizer to commercialise its IP with the help of trailblazing Roivant approach

The partnership is aimed at helping the pharma giant to moentise deprioritised IP in the autoimmune space

04 July 2022

Why IP valuation in Asia has yet to take off

Although various government-led programmes have emerged over the years to encourage activity in the field, writes Joyce Ng, professionals reveal that a lack of transaction data and an absence of corporate buy-in is preventing it from going mainstream

22 June 2022

There’s a lot more to GE Licensing than patents, says outfit’s head

GE’s Licensing group participates in traditional patent licensing while also exploring new models like equity management

20 June 2022

Acacia Research CIPO predicts operating company patent sales

Buyers should position themselves for opportunities as worsening economy spurs monetisation efforts, says Marc Booth

16 June 2022

New IP finance play, Ukraine tribute, patent litigation trends and plenty more as IPBC Global 2022 comes to an end

Despite the close attentions of a tornado and the deadening heatwave that preceded and followed it, delegates and speakers in Chicago were in good form for the final day of this year's event

15 June 2022

The future of FRAND, 6G, IP finance and patent dealmaking take centre stage in Chicago

Day Two of IPBC Global 2022 provided a succession of important contributions from some of the market’s most prominent thought-leaders

14 June 2022

Defendants seek dismissal of lawsuit as litigation funder complicates Samsung verdict profits recovery

University that secured over $200 million in a patent infringement suit against the South Korean giant has yet to see any of the cash

10 June 2022

GSK’s $3.3 billion buyout shows vaccine IP boom goes beyond mRNA

Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital

06 June 2022

Get unlimited access to all IAM content